<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2021-7-46-55</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-6141</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>САХАРНЫЙ ДИАБЕТ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>DIABETES MELLITUS</subject></subj-group></article-categories><title-group><article-title>Анализ времени нахождения в целевом диапазоне в зависимости от метода оценки уровня глюкозы</article-title><trans-title-group xml:lang="en"><trans-title>Analysis of time in range depending on the method of assessing the glucose level</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9253-8075</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Суплотова</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Suplotova</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Суплотова Людмила Александровна - доктор медицинских наук, профессор, заведующая курсом эндокринологии кафедры терапии.</p><p>625000, Россия, Тюмень, ул. Одесская, д. 54.</p></bio><bio xml:lang="en"><p>Lyudmila A. Suplotova - Dr. Sci. (Med.), Professor, Head of Endocrinology Course, Therapy Department, Institute of Continuing Professional Development, Tyumen State Medical University.</p><p>54, Odesskaya St., Tyumen, 625023.</p></bio><email xlink:type="simple">suplotovala@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1932-1686</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Судницына</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Sudnitsyna</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Судницына Анна Сергеевна - аспирант кафедры терапии Института непрерывного профессионального развития с курсом функциональной и ультразвуковой диагностики и эндокринологии, врач-эндокринолог.</p><p>625000, Тюмень, ул. Одесская, д. 54.</p></bio><bio xml:lang="en"><p>Anna S. Sudnitsyna - Postgraduate Student of the Course of the Endocrinology of the Institute of CPD with the Courses of Endocrinology, Functional and Ultrasound Diagnostics, Tyumen State Medical University.</p><p>54, Odesskaya St., Tyumen, 625000.</p></bio><email xlink:type="simple">dr.sudnitsyna@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7124-1176</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Романова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Romanova</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Романова Наталья Валерьяновна - кандидат медицинских наук, заведующая эндокринологическим отделением.</p><p>625039, Тюмень, ул. Мельникайте, д. 75.</p></bio><bio xml:lang="en"><p>Natalia V. Romanova - Cand. Sci. (Med.), Head of the Endocrinology Department, Regional Clinical Hospital №2.</p><p>75, Melnikaite St., Tyumen, 625039.</p></bio><email xlink:type="simple">n.v.romanova2014@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0511-865X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сидоренко</surname><given-names>К. A.</given-names></name><name name-style="western" xml:lang="en"><surname>Sidorenko</surname><given-names>K. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сидоренко Ксения Андреевна - врач-эндокринолог.</p><p>625039, Тюмень, ул. Мельникайте, д. 75.</p></bio><bio xml:lang="en"><p>Kseniya A. Sidorenko - Endocrinologist, Regional Clinical Hospital №2.</p><p>75, Melnikaite St., Tyumen, 625039.</p></bio><email xlink:type="simple">ksu-sidorenko@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1074-237X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Радионова</surname><given-names>Л. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Radionova</surname><given-names>L. U.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Радионова Людмила Юрьевна - главный внештатный специалист Министерства здравоохранения Омской области, заведующая эндокринологическим отделением.</p><p>644112, Омск, ул. Березовая, д. 3.</p></bio><bio xml:lang="en"><p>Ludmila U. Radionova - Chief Freelance Specialist of the Ministry of Health of the Omsk Region, Head of the Endocrinology Department, Regional Clinical Hospital.</p><p>3, Berezovaya St., Omsk, 644112.</p></bio><email xlink:type="simple">ludmilaradionova@yandex.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1573-1765</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Грачева</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gracheva</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Грачева Татьяна Владимировна - кандидат медицинских наук, заведующая эндокринологическим отделением.</p><p>620102, Екатеринбург, ул. Волгоградская, д. 185.</p></bio><bio xml:lang="en"><p>Tatiana V. Gracheva - Cand. Sci. (Med.), Head of the Endocrinology Department, Sverdlovsk Regional Clinical Hospital №1.</p><p>185, Volgograds-kaya St., Ekaterinburg, 620102.</p></bio><email xlink:type="simple">mrs.gracheva@yandex.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6311-1723</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Плотников</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Plotnikov</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Плотников Николай Валерьевич - кандидат медицинских наук, руководитель эндокринологического центра.</p><p>640002, Курган, ул. Томина, д. 63.</p></bio><bio xml:lang="en"><p>Nikolay V. Plotnikov - Cand. Sci. (Med.), Head of the Endocrinological Center, Kurgan Regional Clinical Hospital.</p><p>63, Tomin St., Kurgan, 640002.</p></bio><email xlink:type="simple">pnvkurgan@mail.ru</email><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0355-3554</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хиева</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Khieva</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хиева Екатерина Викторовна - врач-эндокринолог, Курганская областная клиническая больница.</p><p>640002, Курган, ул. Томина, д. 63.</p></bio><bio xml:lang="en"><p>Ekaterina V. Khieva - Endocrinologist, Kurgan Regional Clinical Hospital.</p><p>63, Tomin St., Kurgan, 640002.</p></bio><email xlink:type="simple">khieva@mail.ru</email><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3906-4784</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шабельникова</surname><given-names>О. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Shabelnikova</surname><given-names>O. Y.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шабельникова Олеся Юрьевна - кандидат медицинских наук, заведующий эндокринологическим отделением, руководитель областного эндокринологического центра.</p><p>630087, Новосибирск, ул. Немировича-Данченко, д. 130.</p></bio><bio xml:lang="en"><p>Olesia Y. Shabelnikova - Cand. Sci. (Med.), Head of the Endocrinology Department, Head of the Regional Endocrinological Center, State Novosibirsk Clinical Hospital.</p><p>130, Nemirovich-Danchenko St., Novosibirsk, 630087.</p></bio><email xlink:type="simple">shabelnikova@oblmed.nsk.ru</email><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5614-3970</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ипатко</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ipatko</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ипатко Ирина Алексеевна - главный внештатный специалист - диабетолог Министерства здравоохранения Республики Коми, главный врач, Консультативно-диагностический центр.</p><p>167981, Сыктывкар, ул. Куратова, д. 6.</p></bio><bio xml:lang="en"><p>Irina A. Ipatko - Chief Freelance Specialist, Diabetologist of the Ministry of Health of the Komi Republic, Consultative and Diagnostic Center.</p><p>6, Kuratov St., Syktyvkar, 167981.</p></bio><email xlink:type="simple">irinaipatk@rambler.ru</email><xref ref-type="aff" rid="aff-7"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6868-2704</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жуковец</surname><given-names>Г. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhukovets</surname><given-names>G. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Жуковец Галина Викторовна - главный внештатный консультант по диабетологии Министерства здравоохранения Кировской области, заместитель главного врача по эндокринологической службе, Кировская клиническая больница №7 имени В.И. Юрловой.</p><p>610014, Киров, ул. Свободы, д. 59.</p></bio><bio xml:lang="en"><p>Galina V. Zhukovets - Chief Freelance Consultant for Diabetology, Deputy Chief Physician for Endocrinological Service, Kirov Clinical Hospital №7 named. V.I. Yurlova.</p><p>59, Svoboda St., Kirov, 610014.</p></bio><email xlink:type="simple">zhukovez2010@yandex.ru</email><xref ref-type="aff" rid="aff-8"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1366-1356</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чередникова</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Cherednikova</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чередникова Марина Анатольевна - кандидат медицинских наук, заведующая эндокринологическим отделением.</p><p>454092, Челябинск, ул. Воровского, д. 16.</p></bio><bio xml:lang="en"><p>Marina A. Cherednikova - Cand. Sci. (Med.), Head of the Endocrinology Department, City Clinical Hospital №1.</p><p>16, Vorovsky St., Chelyabinsk, 454092.</p></bio><email xlink:type="simple">marinach@inbox.ru</email><xref ref-type="aff" rid="aff-9"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Тюменский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Tyumen State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Областная клиническая больница №2</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Regional Clinical Hospital №2</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Областная клиническая больница</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Regional Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Свердловская областная клиническая больница №1</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sverdlovsk Regional Clinical Hospital №1</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>Курганская областная клиническая больница</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kurgan Regional Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-6"><aff xml:lang="ru"><institution>Государственная Новосибирская клиническая больница</institution><country>Россия</country></aff><aff xml:lang="en"><institution>State Novosibirsk Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-7"><aff xml:lang="ru"><institution>Консультативно-диагностический центр</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Consultative and Diagnostic Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-8"><aff xml:lang="ru"><institution>Кировская клиническая больница №7 имени В.И. Юрловой</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kirov Clinical Hospital №7 named. V.I. Yurlova</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-9"><aff xml:lang="ru"><institution>Городская клиническая больница №1</institution><country>Россия</country></aff><aff xml:lang="en"><institution>City Clinical Hospital №1</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>12</day><month>05</month><year>2021</year></pub-date><volume>0</volume><issue>7</issue><fpage>46</fpage><lpage>55</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Суплотова Л.А., Судницына А.С., Романова Н.В., Сидоренко К.A., Радионова Л.Ю., Грачева Т.В., Плотников Н.В., Хиева Е.В., Шабельникова О.Ю., Ипатко И.А., Жуковец Г.В., Чередникова М.А., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Суплотова Л.А., Судницына А.С., Романова Н.В., Сидоренко К.A., Радионова Л.Ю., Грачева Т.В., Плотников Н.В., Хиева Е.В., Шабельникова О.Ю., Ипатко И.А., Жуковец Г.В., Чередникова М.А.</copyright-holder><copyright-holder xml:lang="en">Suplotova L.A., Sudnitsyna A.S., Romanova N.V., Sidorenko K.A., Radionova L.U., Gracheva T.V., Plotnikov N.V., Khieva E.V., Shabelnikova O.Y., Ipatko I.A., Zhukovets G.V., Cherednikova M.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/6141">https://www.med-sovet.pro/jour/article/view/6141</self-uri><abstract><sec><title>Введение</title><p>Введение. В последние годы отмечается увеличение распространенности и заболеваемости сахарным диабетом (СД) 1-го типа. Качественный гликемический контроль является определяющим в снижении риска развития и прогрессирования сосудистых осложнений СД. Самоконтроль уровня глюкозы крови (СГК) и профессиональное непрерывное мониторирование уровня глюкозы (ПНМГ) предоставляют массив данных, который должен быть интерпретирован при использовании многочисленных показателей гликемического контроля. Ряд исследователей продемонстрировали взаимосвязь времени нахождения в целевом диапазоне (time in range - TIR) и риска развития хронических осложнений СД. Учитывая недостаточное количество данных о различиях TIR в зависимости от метода оценки уровня глюкозы и значительный потенциал использования данного показателя для стратификации риска осложнений СД, изучение различий TIR на основании данных ПНМГ и СГК является актуальным в настоящее время.</p></sec><sec><title>Цель</title><p>Цель. Оценить время нахождения в целевом диапазоне по данным профессионального непрерывного мониторирования уровня глюкозы и самоконтроля уровня глюкозы крови у пациентов с сахарным диабетом 1-го типа для улучшения контроля течения заболевания.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Интервенционное открытое многоцентровое исследование у пациентов с сахарным диабетом 1-го типа. В исследование включены пациенты с СД 1-го типа в возрасте 18 лет и старше, длительностью заболевания более 1 года, получающие терапию аналоговыми инсулинами. Выполнялся расчет показателей времени нахождения в диапазонах гликемии на основании данных ПНМГ и СГК.</p></sec><sec><title>Результаты и обсуждение</title><p>Результаты и обсуждение. Обследовано 218 пациентов, соответствующих критериям включения и не имеющих критериев исключения. Проанализированные данные демонстрируют статистически незначимые различия в оценке времени нахождения в диапазонах гликемии между данными СГК и ПНМГ.</p></sec><sec><title>Выводы</title><p>Выводы. При оценке показателей времени нахождения в диапазонах гликемии, полученных на основании данных ПНМГ и СГК, продемонстрированы четкие корреляционные взаимосвязи и линейная зависимость, что свидетельствует о сопоставимости этих параметров вне зависимости от метода измерения.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. In recent years, there has been an increase in the prevalence and incidence diabetes type 1. The high-quality glycemic control is critical in reducing the risk of developing and progression of vascular complications and adverse outcomes of diabetes. Self-monitoring blood glucose (SMBG) and professional continuous glucose monitoring (PCGM) provide the data set which must be interpreted using multiple indicators of glycemic control. A number of researchers have demonstrated the relationship between the time in range (TIR) and the risk of developing both micro- and macrovascular complications of diabetes. Considering the insufficient amount of data on TIR differences depending on the glucose level assessment method and the significant potential of using this indicator for the stratification of the risk of both micro- and macrovascular complications of diabetes, the study of TIR differences based on the data of PCGM and SMBG is relevant at present.</p></sec><sec><title>Aims</title><p>Aims. To estimate the time range according to professional continuous glucose monitoring and self-monitoring of blood glucose levels in the patients with diabetes type 1 among the adult population to improve the control of the disease course.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. An interventional open-label multicenter study in the patients with diabetes type 1 was conducted. The patients with diabetes type 1 aged 18 and older, with the disease duration of more than 1 year receiving the therapy with analog insulin was enrolled into the study. The calculation of the indicators of the time spent in the ranges of glycemia was carried out on the basis of the data of PCGM and SMBG.</p></sec><sec><title>Results and discussion</title><p>Results and discussion. We examined 218 patients who met the inclusion criteria and did not have exclusion criteria. The presented differences in the indicators of time in ranges indicate the comparability of the SMBG and PCGM methods.</p></sec><sec><title>Conclusions</title><p>Conclusions. When assessing the indicators of time in the ranges of glycemia obtained on the basis of the data of PCGM and SMBG, clear correlations and linear dependence were demonstrated, which indicates the comparability of these parameters regardless of the measurement method.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>время нахождения в целевом диапазоне</kwd><kwd>сахарный диабет 1-го типа</kwd><kwd>уровень глюкозы крови</kwd><kwd>самоконтроль</kwd><kwd>профессиональное непрерывное мониторирование уровня глюкозы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>time in range</kwd><kwd>diabetes type 1</kwd><kwd>blood glucose levels</kwd><kwd>self-monitoring</kwd><kwd>professional continuous glucose monitoring</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Foster N.C., Beck R.W., Miller K.M., Clements M.A., Rickels M.R., Dimeglio L.A. et al. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018. Diabetes Technol Ther. 2019;21(2):66-72. doi: 10.1089/dia.2018.0384.</mixed-citation><mixed-citation xml:lang="en">Foster N.C., Beck R.W., Miller K.M., Clements M.A., Rickels M.R., Dimeglio L.A. et al. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018. Diabetes Technol Ther. 2019;21(2):66-72. doi: 10.1089/dia.2018.0384.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Miller K.M., Foster N.C., Beck R.W., Bergensta R.M., DuBose S.N., DiMeglio L.A. et al. Current state of type 1 diabetes treatment in the U.S.: Updated data from the t1d exchange clinic registry. Diabetes Care. 2015;38(6):971-978. doi: 10.2337/dc15-0078.</mixed-citation><mixed-citation xml:lang="en">Miller K.M., Foster N.C., Beck R.W., Bergensta R.M., DuBose S.N., DiMeglio L.A. et al. Current state of type 1 diabetes treatment in the U.S.: Updated data from the t1d exchange clinic registry. Diabetes Care. 2015;38(6):971-978. doi: 10.2337/dc15-0078.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Pettus J.H., Zhou F.L., Shepherd L., Preblick R., Hunt P.R., Paranjape S. et al. Incidences of severe hypoglycemia and diabetic ketoacidosis and prevalence of microvascular complications stratified by age and glycemic control in U.S. Adul tpatients with type 1 diabetes: A real-world study. Diabetes Care. 2019;42(12):2220-2227. doi: 10.2337/dc19-0830.</mixed-citation><mixed-citation xml:lang="en">Pettus J.H., Zhou F.L., Shepherd L., Preblick R., Hunt P.R., Paranjape S. et al. Incidences of severe hypoglycemia and diabetic ketoacidosis and prevalence of microvascular complications stratified by age and glycemic control in U.S. Adul tpatients with type 1 diabetes: A real-world study. Diabetes Care. 2019;42(12):2220-2227. doi: 10.2337/dc19-0830.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Beck R.W., Connor C.G., Mullen D.M., Wesley D.M., Bergenstal R.M. The fallacy of average: How using hba1c alone to assess glycemic control can be misleading. Diabetes Care. 2017;40(8):994-999. doi: 10.2337/dc17-0636.</mixed-citation><mixed-citation xml:lang="en">Beck R.W., Connor C.G., Mullen D.M., Wesley D.M., Bergenstal R.M. The fallacy of average: How using hba1c alone to assess glycemic control can be misleading. Diabetes Care. 2017;40(8):994-999. doi: 10.2337/dc17-0636.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Hempe J.M., Liu S., Myers L., McCarter R.J., Buse J.B., Fonseca V. The hemoglobin glycation index identifies subpopulations with harms or benefits in the ACCORD trial. Diabetes Care. 2015;38(10):1067-1074. doi: 10.2337/dci15-0001.</mixed-citation><mixed-citation xml:lang="en">Hempe J.M., Liu S., Myers L., McCarter R.J., Buse J.B., Fonseca V. The hemoglobin glycation index identifies subpopulations with harms or benefits in the ACCORD trial. Diabetes Care. 2015;38(10):1067-1074. doi: 10.2337/dci15-0001.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Malka R., Nathan D.M., Higgins J.M. Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring. Sci Transl Med. 2016;8(359):359ra130. doi: 10.1126/scitranslmed.aaf9304.</mixed-citation><mixed-citation xml:lang="en">Malka R., Nathan D.M., Higgins J.M. Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring. Sci Transl Med. 2016;8(359):359ra130. doi: 10.1126/sci-translmed.aaf9304.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">American Diabetes Association. 6. Glycemic Targets. Diabetes Care. 2017;40(1 Suppl.):48-56. doi: 10.2337/dc17-S009.</mixed-citation><mixed-citation xml:lang="en">American Diabetes Association. 6. Glycemic Targets. Diabetes Care. 2017;40(1 Suppl.):48-56. doi: 10.2337/dc17-S009.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ajjan R.A., Cummings M.H., Jennings P., Leelarathna L., Rayman G., Wilmot E.G. Accuracy of flash glucose monitoring and continuous glucose monitoring technologies: Implications for clinical practice. Diabetes Vasc Dis Res. 2018;15(3):175-184. doi: 10.1177/1479164118756240.</mixed-citation><mixed-citation xml:lang="en">Ajjan R.A., Cummings M.H., Jennings P., Leelarathna L., Rayman G., Wilmot E.G. Accuracy of flash glucose monitoring and continuous glucose monitoring technologies: Implications for clinical practice. Diabetes Vasc Dis Res. 2018;15(3):175-184. doi: 10.1177/1479164118756240.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Poolsup N., Suksomboon N., Kyaw A.M. Systematic review and meta-analy-sis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes. Diabetol Metab Syndr. 2013;5:39. doi: 10.1186/1758-5996-5-39.</mixed-citation><mixed-citation xml:lang="en">Poolsup N., Suksomboon N., Kyaw A.M. Systematic review and meta-analy-sis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes. Diabetol Metab Syndr. 2013;5:39. doi: 10.1186/1758-5996-5-39.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Oliver N. Continuous glucose monitoring adoption in the United Kingdom - An economic and policy perspective. Eur Endocrinol. 2017;13(2):73-75. doi: 10.17925/EE.2017.13.02.73.</mixed-citation><mixed-citation xml:lang="en">Oliver N. Continuous glucose monitoring adoption in the United Kingdom - An economic and policy perspective. Eur Endocrinol. 2017;13(2):73-75. doi: 10.17925/EE.2017.13.02.73.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Tanenbaum M.L., Hanes S.J., Miller K.M., Naranjo D., Bensen R., Hood K.K. Diabetes device use in adults with type 1 diabetes: Barriers to uptake and potential intervention targets. Diabetes Care. 2017;40(2):181-187. doi: 10.2337/dc16-1536.</mixed-citation><mixed-citation xml:lang="en">Tanenbaum M.L., Hanes S.J., Miller K.M., Naranjo D., Bensen R., Hood K.K. Diabetes device use in adults with type 1 diabetes: Barriers to uptake and potential intervention targets. Diabetes Care. 2017;40(2):181-187. doi: 10.2337/dc16-1536.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Шестакова М.В., Майоров А.Ю. (ред.). Алгоритмы специализированной медицинской помощи больным сахарным диабетом. 9-й выпуск. Сахарный диабет. 2019;22(1S1):1-144. doi: 10.14341/DM221S1.</mixed-citation><mixed-citation xml:lang="en">Dedov I.I., Shestakova M.V., Mayorov A.Y. (eds.). Standards of Specialized Diabetes Care. 9th edition. Saharnyy diabet = Diabetes Mellitus. 2019;22(1 Suppl.):1-144. (In Russ.) doi: 10.14341/DM221S1.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Шестакова М.В., Майоров А.Ю., Шамхалова М.Ш., Никонова Т.В., Сухарева О.Ю. и др. Сахарный диабет 1-го типа у взрослых: клинические рекомендации. М.; 2019. 167 с. Режим доступа: https://rae-org.ru/system/files/documents/pdf/saharnyy_diabet_1_tipa_u_vzroslyh.pdf.</mixed-citation><mixed-citation xml:lang="en">Dedov I.I., Shestakova M.V., Mayorov A.YU., Shamkhalova M.SH., Nikonova T.V., Sukhareva O.Yu. et al. Type 1 diabetes mellitus in adults: clinical guidelines. Moscow; 2019. 167 p. (In Russ.) Available at: https://rae-org.ru/system/files/documents/pdf/saharnyy_diabet_1_tipa_u_vzroslyh.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Шестакова М.В., Майоров А.Ю., Филиппов Ю.И., Ибрагимова Л.И., Пекарева Е.В., Лаптев Д.Н. и др. Федеральные клинические рекомендации по помповой инсулинотерапии и непрерывному мониторированию гликемии у больных сахарным диабетом. ПРОЕКТ. Проблемы эндокринологии. 2015;61(6):55-78. doi: 10.14341/probl201561655-78.</mixed-citation><mixed-citation xml:lang="en">Shestakova M.V., Mayorov A.Yu., Ibragimova L.I., Pekareva E.V., Laptev D.N., Glazunova A.M. et al. Russian national guidelines on insulin pump therapy and continuous glycose monitoring diabetes mellitus patients. DRAFT. Problemy endokrinologii = Problems of Endocrinology. 2015;61(6):55-78. (In Russ.) doi: 10.14341/probl201561655-78.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Danne T., Nimri R., Battelino T., Bergenstal R.M., Close K.L., DeVries J.H. et al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017;40(12):1631-1640. doi: 10.2337/dc17-1600.</mixed-citation><mixed-citation xml:lang="en">Danne T., Nimri R., Battelino T., Bergenstal R.M., Close K.L., DeVries J.H. et al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017;40(12):1631-1640. doi: 10.2337/dc17-1600.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Nathan D.M. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: Overview. Diabetes Care. 2014;37(1):9-16. doi: 10.2337/dc13-2112.</mixed-citation><mixed-citation xml:lang="en">Nathan D.M. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: Overview. Diabetes Care. 2014;37(1):9-16. doi: 10.2337/dc13-2112.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Mayeda L., Katz R., Ahmad I., Bansal N., Batacchi Z., Hirsch I.B. et al. Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease. BMJ Open Diabetes Res Care. 2020;8(1):e000991. doi: 10.1136/bmjdrc-2019-000991.</mixed-citation><mixed-citation xml:lang="en">Mayeda L., Katz R., Ahmad I., Bansal N., Batacchi Z., Hirsch I.B. et al. Glucose time in range and peripheral neuropathy in type 2 diabetes mel-litus and chronic kidney disease. BMJ Open Diabetes Res Care. 2020;8(1):e000991. doi: 10.1136/bmjdrc-2019-000991.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Beck R.W., Bergenstal R.M., Riddlesworth T.D., Kollman C., Li Z., Brown A.S., Close K.L. Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care. 2019;42(3):400-405. doi: 10.2337/dc18-1444.</mixed-citation><mixed-citation xml:lang="en">Beck R.W., Bergenstal R.M., Riddlesworth T.D., Kollman C., Li Z., Brown A.S., Close K.L. Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care. 2019;42(3):400-405. doi: 10.2337/dc18-1444.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Avari P., Uduku C., George D., Herrero P., Reddy M., Oliver N. Differences for Percentage Times in Glycemic Range between Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring in Adults with Type 1 Diabetes: Analysis of the REPLACE-BG Dataset. Diabetes Technol Ther. 2020;22(3):222-227. doi: 10.1089/dia.2019.0276.</mixed-citation><mixed-citation xml:lang="en">Avari P., Uduku C., George D., Herrero P., Reddy M., Oliver N. Differences for Percentage Times in Glycemic Range between Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring in Adults with Type 1 Diabetes: Analysis of the REPLACE-BG Dataset. Diabetes Technol Ther. 2020;22(3):222-227. doi: 10.1089/dia.2019.0276.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Fiallo-Scharer R. Eight-point glucose testing Versus the continuous glucose monitoring system in evaluation of glycemic control in type 1 diabetes. J Clin Endocrinol Metab. 2005;90(6):3387-3391. doi: 10.1210/jc.2004-2510.</mixed-citation><mixed-citation xml:lang="en">Fiallo-Scharer R. Eight-point glucose testing Versus the continuous glucose monitoring system in evaluation of glycemic control in type 1 diabetes. J Clin Endocrinol Metab. 2005;90(6):3387-3391. doi: 10.1210/jc.2004-2510.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Beck R.W., Calhoun P., Kollman C. Use of continuous glucose monitoring as an outcome measure in clinical trials. Diabetes Technol Ther. 2012;14(10):877-882. doi: 10.1089/dia.2012.0079.</mixed-citation><mixed-citation xml:lang="en">Beck R.W., Calhoun P., Kollman C. Use of continuous glucose monitoring as an outcome measure in clinical trials. Diabetes Technol Ther. 2012;14(10): 877-882. doi: 10.1089/dia.2012.0079.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Battelino T., Danne T., Bergenstal R.M., Amiel S.A., Beck R., Biester T. et al. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593-1603. doi: 10.2337/dci19-0028.</mixed-citation><mixed-citation xml:lang="en">Battelino T., Danne T., Bergenstal R.M., Amiel S.A., Beck R., Biester T. et al. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593-1603. doi: 10.2337/dci19-0028.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Michalak A., Pagacz K., Mtynarski W., Szadkowska A., Fendler W. Discrepancies between methods of continuous glucose monitoring in key metrics of glucose control in children with type 1 diabetes. Pediatr Diabetes. 2019;20(5):604-612. doi: 10.1111/pedi.12854.</mixed-citation><mixed-citation xml:lang="en">Michalak A., Pagacz K., Mtynarski W., Szadkowska A., Fendler W. Discrepancies between methods of continuous glucose monitoring in key metrics of glucose control in children with type 1 diabetes. Pediatr Diabetes. 2019;20(5):604-612. doi: 10.1111/pedi.12854.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
